🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Malbork
Clinical trial register · Poland

Clinical Trials in Malbork, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Poland and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 2681 matching records held by the registry are in this view. Synced 26 Sep 2026, 19:47 UTC
2681
Studies in scope
all four open statuses
1400
Recruiting now
open to new participants
514
Lead sponsors
across recruiting studies
Top sites
Warsaw 1297 Krakow 869 Poznan 699 Gdansk 656 Lodz 622
Narrow the registerReset
Recruitment status
Phase
Site location
Warsaw1297 Krakow869 Poznan699 Gdansk656 Lodz622
All 261 locations
Target enrolment
to

Trials with a site in Malbork

16 of 2681 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Poland
Start
Recruiting
Panuri Performance Study
NCT07587866Pancreatic Ductal Adenocarcinoma (PDAC)
Urteste S.A
Observational
1,100
Dąbrowa Tarnowska, Gdansk, Grudziądz, Iława, Krakow, Lodz, Lublin, Malbork
2026-06-10
Recruiting
LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
NCT07415044Ulcerative Colitis (UC), Ulcerative Colitis, Active Moderate, Ulcerative Colitis, Active Severe
Eli Lilly and Company
Phase 2
1,431
Chorzów, Katowice, Kielce, Krakow, Lodz, Malbork, Nowy Targ, Poznan
2026-03-26
Recruiting
A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease
NCT07332481Systemic Lupus Erythematosus (SLE), Cutaneous Lupus Erythematosus (CLE)
EMD Serono Research & Development Institute, Inc.
Phase 3
202
Krakow, Lublin, Malbork, Rzeszów, Zamość
2026-03-10
Recruiting
A Study of Zasocitinib in Adults With Hidradenitis Suppurativa
NCT07244263Hidradenitis Suppurativa
Takeda
Phase 2
90
Wroclaw, Warsaw, Rzeszów, Malbork
2026-01-26
Not yet open
URGO FilmoCream Eczema + Dermocorticoids in Atopic Dermatitis
NCT07295678Atopic Dermatitis
CEN Biotech
Not applicable
44
Gdansk, Malbork
2026-01-05
Recruiting
Study of the Efficacy and Safety of ICP-332 in Participants With Prurigo Nodularis
NCT07236099Prurigo Nodularis (PN)
Beijing InnoCare Pharma Tech Co., Ltd.
Phase 2
135
Bialystok, Gdansk, Kielce, Lodz, Malbork, Nowa Sól, Poznan, Rzeszów
2025-11-27
Active, closed
A Study Evaluating BFB759 in Moderate to Severe Atopic Dermatitis
NCT07105488Atopic Dermatitis (AD)
DrugBFB759
Bluefin Biomedicine, Inc.
Phase 2
225
Bialystok, Bydgoszcz, Chorzów, Gdansk, Grodzisk Mazowiecki, Krakow, Malbork, Ostrowiec Świętokrzyski
2025-07-15
Active, closed
Tibulizumab Skin Healing and Inflammation Evaluation for Lasting Defense
NCT06993610Hidradenitis Suppurativa (HS)
Zura Bio Inc
Phase 2
225
Bialystok, Katowice, Malbork, Poznan, Szczecin, Warsaw
2025-05-16
Recruiting
Long-Term Safety and Efficacy of Plozasiran in Adults With Hypertriglyceridemia
NCT06822790Hypertriglyceridemia
Arrowhead Pharmaceuticals
Phase 3
869
Elblag, Gdynia, Katowice, Krakow, Lodz, Malbork, Szczecin, Warsaw
2025-04-09
Active, closed
A Study to Evaluate the Efficacy and Safety of Subcutaneous Tildrakizumab in Subjects With Moderate to Severe Genital Psoriasis.
NCT06611163Moderate to Severe Genital Psoriasis
Sun Pharmaceutical Industries Limited
Phase 3
206
Wroclaw, Lublin, Krakow, Rzeszw, Malbork, Bialystok-Podlaskie, Katowice, Warsaw
2025-03-21
Active, closed
Efficacy of Cosmetic Product RV3278B-OS0386 in the Maintenance Phase After Oral Isotretinoin Treatment of Adults Subjects With Facial Acne.
NCT07341659Acne
Pierre Fabre Dermo Cosmetique
Not applicable
102
Malbork, Gdansk
2025-02-28
Recruiting
A Long-term Extension Study of Dazodalibep in Participants With Sjögren's Syndrome (SS)
NCT06747949Sjögren's Syndrome
Amgen
Phase 3
844
Poznan, Krakow, Wroclaw, Lublin, Warsaw, Wołomin, Malbork, Bydgoszcz
2025-02-25
Active, closed
Study of Plozasiran in Adults With Severe Hypertriglyceridemia
NCT06347016Severe Hypertriglyceridemia
Arrowhead Pharmaceuticals
Phase 3
311
Bydgoszcz, Gdynia, Katowice, Lodz, Malbork, Szczecin, Torun, Wroclaw
2024-07-23
Active, closed
A Safety and Efficacy Study of Dazodalibep in Participants With Sjögren's Syndrome (SS) With Moderate-to-Severe Symptom State
NCT06245408Sjögren's Syndrome (SS)
Amgen
Phase 3
434
Krakow, Wroclaw, Lublin, Warsaw, Wołomin, Malbork, Bydgoszcz, Katowice
2024-04-08
By invitation
A Study to Learn More About the Long-Term Safety of Litifilimab (BIIB059) Injections and it's Effects on Symptoms in Adults With Systemic Lupus Erythematosus (SLE)
NCT05352919Systemic Lupus Erythematosus (SLE)
Biogen
Phase 3
864
Bialystok, Bydgoszcz, Bytom, Krakow, Malbork, Poznan, Warsaw
2022-06-10
Active, closed
A Study to Learn About the Safety of Litifilimab (BIIB059) Injections and Whether They Can Improve Symptoms of Adult Participants Who Have Systemic Lupus Erythematosus
NCT04895241Lupus Erythematosus, Systemic
Biogen
Phase 3
548
Bialystok, Bydgoszcz, Bytom, Krakow, Lublin, Malbork, Nowa Sól, Poznan
2021-05-25
Rows per page Showing 1–16 of 16
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Polish investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 28 September 2026. https://priyalifescience.com/clinical-trials-poland/city/malbork

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Poland and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 2,681 studies in total at the last sync on 26 Sep 2026, 19:47 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 16 of those studies with a site in Malbork.

How many clinical trials are recruiting in Malbork?

7 of the 16 studies on this page are recruiting new participants as of the 26 Sep 2026, 19:47 UTC sync. A further 1 have not yet opened recruitment, 7 are active but closed to new participants, and 1 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Malbork), 16 studies
PhaseStudiesRecruitingShare
Phase 38350%
Phase 25331.3%
Not applicable2012.5%
Observational116.3%

Most active sponsors

Lead sponsors with the most studies (Malbork)
Lead sponsorStudiesRecruiting
Amgen21
Arrowhead Pharmaceuticals21
Biogen20
Beijing InnoCare Pharma Tech Co., Ltd.11
Bluefin Biomedicine, Inc.10
CEN Biotech10
Eli Lilly and Company11
EMD Serono Research & Development Institute, Inc.11
Pierre Fabre Dermo Cosmetique10
Sun Pharmaceutical Industries Limited10
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.